Article
p53: a guide to apoptosis.
Current cancer drug targets - 1 Mar 2008
Meulmeester Erik, Jochemsen Aart G
Abstract excerpt
Approximately 50% of sporadic human tumors harbor somatic mutations in the p53 gene locus, while germ line mutations confer a high familial risk and are associated with Li-Fraumeni Syndrome patients. The p53 tumor suppressor protein is often referred to as the "guardian of the genome" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses. One of the most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
